Clinical, demographic and pathogen data for the 103 isolates included in the study
| Variable | No. (%*†) |
| No. of patients | 103 |
| Male gender (%) | 71 (69) |
| Age | |
| 10–19 | 21 (20) |
| 20–29 | 46 (45) |
| 30–39 | 13 (13) |
| 40–49 | 11 (11) |
| 50–59 | 7 (7) |
| 60–69 | 2 (2) |
| 70–79 | 2 (2) |
| Missing | 1 (1) |
| HIV positive | 5 (5) |
| Radiological pathology % of lung involved (median/IQR) | 30 (15–50) |
| Drug susceptibility status | |
| Mono-resistant | 12 (12) |
| MDR | 91 (88) |
| Previous tuberculosis disease | 30 (29) |
| Lineage | |
| Lineage 2.2.1 | 7 (7) |
| Lineage 4 | 7 (7) |
| Lineage 4.1 | 1 (1) |
| Lineage 4.1.1 | 5 (5) |
| Lineage 4.1.1.3 | 4 (4) |
| Lineage 4.1.2.1 | 10 (10) |
| Lineage 4.3.2 | 4 (4) |
| Lineage 4.3.3 | 43 (42) |
| Lineage 4.3.4.1 | 4 (4) |
| Lineage 4.3.4.2 | 17 (16) |
| Lineage 4.8 | 1 (1) |
*% total 101 due to rounding.
†No missing data unless stated.
MDR, multidrug resistant .